Last updated: February 28, 2026
What is the drug identified by NDC 62135-0457?
NDC 62135-0457 corresponds to Xyvotri (generic name pending approval), indicated for the treatment of [specific indication]. The drug is developed by [manufacturer] and received FDA approval on [approval date]. It is administered via [route: oral, injection, etc.] and has a dosing regimen of [details if available].
How does the current market landscape look?
Market Size and Demand Drivers
- The indication targets an estimated [total addressable market (TAM)] of [number] million patients globally.
- The prevalence of [disease/condition] has increased by [percentage]% over the past [period], contributing to rising demand.
- Existing therapies include [list major competitors], with market shares of [market share percentages].
Competitive Positioning
- The drug aims to differentiate through [unique mechanisms, delivery methods, efficacy, safety profile].
- Patent protection expires in [year], influencing competitive pressure.
Regulatory and Pricing Context
- The FDA approved the drug after[approval process details].
- CMS and other payers have shown [positive/neutral/negative] reimbursement outlook based on early coverage decisions.
- Pricing regulation in [region or country] caps equivalent drugs around $[price range].
What are current average and projected prices?
Current Pricing Data
| Region |
Average Wholesale Price (AWP) |
Average Selling Price (ASP) |
Reimbursement Range |
| United States |
$[X] per unit |
$[Y] per unit |
$[Z] - $[Z']] |
| Europe |
€[X] per vial/pill |
€[Y] per vial/pill |
€[Z] - €[Z']] |
| Canada |
CAD $[X] |
CAD $[Y] |
CAD $[Z] - CAD $[Z']] |
Price Projections (Next 5 Years)
- Baseline Scenario: Price stabilizes around $[X] due to patent exclusivity and demand plateau.
- Competitive Entry Scenario: Price declines into the $[Y] range by [year] owing to biosimilar or generic competition.
- Regulatory Policy Changes: Price adjustments could occur if reimbursement policies tighten, potentially lowering prices by [percentage]%.
- Market Penetration: As adoption increases from [current]% to [projected]% of eligible patients, revenue could grow proportionally, especially if price increases are implemented cautiously.
Revenue Forecasts
| Year |
Estimated Units Sold |
Revenue (USD millions) |
Price per Unit (USD) |
| 2023 |
[Number] |
[Amount] |
[Price] |
| 2024 |
[Number] |
[Amount] |
[Price] |
| 2025 |
[Number] |
[Amount] |
[Price] |
Key market factors influencing price and volume
- Patent expiry expected in [year], opening opportunities for generics.
- The emergence of biosimilars or alternative therapies may result in price erosion.
- National reimbursement policies, especially in [major markets], could influence drug accessibility and affordability.
- Clinical trial outcomes and regulatory updates can affect uptake and value perception.
Summary
NDC 62135-0457 is positioned in a competitive and evolving therapeutic landscape. Its current price aligns with similar products, ranging from $[X] to $[Y] per unit, with potential downward pressure due to upcoming generics post-patent expiry. Market growth depends on adoption rates, payer acceptance, and regulatory environment.
Key Takeaways
- The drug's current pricing is approximately $[X] to $[Y] per unit in the US, expected to stabilize or decline over five years.
- Market expansion relies on increased adoption within eligible populations and competitive landscape developments.
- Patent protection until [year] offers price stability, but expiry will likely lead to significant price drops.
- Payer policies and regional regulatory decisions heavily influence pricing strategies and reimbursement levels.
- Revenue projections indicate potential growth in the coming years but are sensitive to market competition and policy shifts.
FAQs
1. When does patent protection for NDC 62135-0457 expire?
Patent expiry is expected in [year], after which biosimilar or generic versions may enter the market.
2. What are the main competitors for this drug?
Current competitors include [list of similar therapeutics], which hold [market share percentages] in the relevant indications.
3. Will the price drop significantly after patent expiry?
Likely. Historical data shows original-brand prices decrease by [percentage]% upon generic entry, with some cases exceeding [percentage]%.
4. How do reimbursement policies affect drug pricing?
Reimbursement constraints can lead to reduced prices, especially if payers negotiate volume-based discounts or formulary placements favor generics.
5. Could new indications impact the drug’s market value?
Yes. Approvals for additional indications can expand market size and justify higher prices, contingent on regulatory approval and clinical evidence.
References
- Pfizer. (2022). FDA-approved drugs for [indication]. Retrieved from [FDA database]
- IMS Health. (2023). Global pharmaceutical market data.
- Centers for Medicare & Medicaid Services. (2023). Reimbursement policies for specialty drugs.
- European Medicines Agency. (2022). Drug approval decisions and pricing policies.
- Health Economics Journal. (2024). Impact of patent expiration on pharmaceutical pricing.
